Pharmadrug Inc. (TSE:PHRX) has released an update.
PharmaDrug Inc. has announced their subsidiary SecureDose’s collaboration with Chiral Labs to develop a novel biosynthetic cocaine synthesis method aimed at producing pharmaceutical grade cocaine for safe supply programs. The process, which is expected to take 7-9 months to complete, will be wholly owned by SecureDose and is part of PharmaDrug’s commitment to harm reduction and controlled substance management. The company’s approach could revolutionize the supply chain and create new revenue streams through global partnerships.
For further insights into TSE:PHRX stock, check out TipRanks’ Stock Analysis page.
